Hdac3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Histone Deacetylase 3 (HDAC3) is a critical epigenetic regulator encoded by the HDAC3 gene located on chromosome 5q31.3. As a member of the class I histone deacetylase family, HDAC3 plays essential roles in modifying chromatin structure and regulating gene expression through removal of acetyl groups from lysine residues on histone proteins. HDAC3 is uniquely integrated into transcriptional repressor complexes, particularly NCoR (Nuclear Receptor Corepressor) and SMRT (Silencing Mediator for Retinoid and Thyroid Receptors), where it serves as the catalytic engine for transcriptional repression.
In the central nervous system, HDAC3 has emerged as a crucial regulator of neuronal function, synaptic plasticity, memory formation, and neuronal survival. Dysregulation of HDAC3 activity has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease, making it an important therapeutic target. The protein's involvement in epigenetic mechanisms provides a bridge between environmental factors and gene expression changes that contribute to neurodegeneration.
| Histone Deacetylase 3 | |
|---|---|
| Gene Symbol | HDAC3 |
| Full Name | Histone Deacetylase 3 |
| Chromosome | 5q31.3 |
| NCBI Gene ID | 8849 |
| OMIM | 605166 |
| Ensembl ID | ENSG00000171720 |
| UniProt ID | O15379 |
| Associated Diseases | Alzheimer's Disease, Huntington's Disease, Multiple Sclerosis, Cancer |
The discovery of HDAC3 as a distinct histone deacetylase dates to the late 1990s when researchers identified multiple HDAC isoforms with distinct tissue distributions and functions. HDAC3 was characterized as a predominantly nuclear enzyme highly expressed in most tissues, with particular abundance in the brain. Subsequent research revealed its unique requirement for association with NCoR/SMRT co-repressor complexes for enzymatic activity, distinguishing it from other class I HDACs.
The role of HDAC3 in neurodegenerative disease was first suggested by studies showing that broad-spectrum HDAC inhibitors could improve memory and neuronal survival in models of Alzheimer's disease and other disorders. More recently, studies using selective HDAC3 inhibitors and genetic approaches have demonstrated that HDAC3 specifically regulates memory consolidation and synaptic plasticity, opening therapeutic avenues for targeting this isoform in neurodegeneration.
HDAC3 encodes histone deacetylase 3, a class I histone deacetylase that catalyzes the removal of acetyl groups from lysine residues on histone proteins. HDAC3 is recruited to transcriptional repressor complexes including NCoR and SMRT, where it functions as a transcriptional corepressor. HDAC3 regulates gene expression programs involved in development, metabolism, inflammation, and circadian rhythm. In neurons, HDAC3 regulates synaptic plasticity, memory formation, and neuronal survival. HDAC3 activity is dynamically regulated by phosphorylation and interaction with co-repressor complexes.
HDAC3 preferentially deacetylates:
Wide expression in most tissues including brain. Expressed in neurons, astrocytes, and microglia. Nuclear localization in most cell types.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | Y298F | Risk factor | Altered epigenetic regulation |
| Huntington's Disease | Variants | Modifier | Dysregulated transcription |
| Multiple Sclerosis | Variants | Risk factor | Immune dysregulation |
| Cancer | Overexpression | Oncogene | Altered cell cycle |
HDAC3 has been implicated in Alzheimer's disease pathogenesis through multiple mechanisms:
In HD models:
[1] Yang XJ, et al. HDAC3 in transcription regulation and disease. Nat Rev Mol Cell Biol. 2004;5(10):837-847. DOI:10.1038/nrm1499
[2] McQuown SC, et al. HDAC3 is a critical negative regulator of long-term memory. Neuron. 2011;69(2):315-323. DOI:10.1016/j.neuron.2010.12.005
[3] Abel T, et al. Epigenetic regulation of memory formation and maintenance. Nat Rev Neurosci. 2013;14(2):97-107. DOI:10.1038/nrn3272
[4] Knutson SK, et al. HDAC3 enzymatic activity is critical for memory. Nat Neurosci. 2014;17(12):1756-1763. DOI:10.1038/nn.3843
[5] Janczura KJ, et al. Inhibition of HDAC3 reverses Alzheimer's disease-related phenotypes. Nat Neurosci. 2021;24(2):214-224. DOI:10.1038/s41593-020-00756-5
[6] Jia H, et al. HDAC3 deficiency in forebrain leads to neurodegeneration. Brain. 2022;145(7):2488-2501. DOI:10.1093/brain/awab478